Provident Pharm

Provident Pharm., Inc. was a United States-based specialty pharmaceutical company primarily focused on the development and commercialization of generic drug products. The company is best known for holding the Abbreviated New Drug Application (ANDA) for Metformin Hydrochloride Extended-Release Tablets, which received FDA approval in July 2006. Provident Pharm was involved in notable legal proceedings, including a 2008 lawsuit against Amneal Pharmaceuticals regarding generic drug marketing and trade secrets in the Eastern District of Virginia. By 2018, the company's primary drug products were listed as discontinued in the FDA Orange Book, and the company appears to have ceased active operations.